D. Claxton

发表

T-cell blast crisis of chronic myelogenous leukemia manifesting as a large mediastinal tumor.

M. Gulley, F. Craig, Jeanne E. Anderson, 2002, Human pathology.

Low-dose total body irradiation promotes T-cells donor chimerism in reduced-intensity/non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide

V. Brown, S. Mineishi, Shouhao Zhou, 2022, Leukemia Research.

Characterization of the ETO and AML1–ETO proteins involved in the 8;21 translocation in acute myelogenous leukemia

S. Kornblau, X. Le, K. Chang, 1998, European journal of haematology.

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia

E. Estey, M. Andreeff, N. Ueno, 2001, American journal of hematology.

Cellular composition of rat bone marrow stroma. Antigen-defined subpopulations.

D. Claxton, A. Sullivan, G. Shematek, 1989, Laboratory investigation; a journal of technical methods and pathology.

Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis

V. Brown, S. Mineishi, H. Shike, 2022, Annals of Hematology.

Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion

V. Brown, S. Mineishi, B. Wirk, 2021, Annals of Hematology.

IMPROVE-BMT: a protocol for a pilot randomised controlled trial of prehabilitation exercise for adult haematopoietic stem cell transplant recipients

B. Zemel, S. Mineishi, K. Schmitz, 2023, BMJ Open.

Isolation of Both Normal and Leukemic Cells Within the Hematopoietic Stem Cell Compartment of Chronic Myelogenous Leukemia Mobilized Peripheral Blood

R. Hoffman, R. Negrin, A. Tsukamoto, 2020 .

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

N. Ueno, B. Andersson, M. Keating, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome.

J. Warrington, J. Zavadil, A. Chinault, 1994, Blood.

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.

E. Estey, H. Kantarjian, S. Kornblau, 1997, Blood.

Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci.

P. Nowell, E. Green, H. Liang, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.

H. Kantarjian, F. Cabanillas, A. Younes, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.

P. Thall, M. Andreeff, N. Ueno, 2001, Blood.

Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia.

K. Kliche, M. Andreeff, U. Popat, 1997, Blood.

Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML.

S. Heimfeld, W. Anderson, H. Kantarjian, 1994, Blood.

Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.

N. Ueno, K. Cleary, B. Andersson, 1999, Blood.

Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia.

E. Estey, A. Deisseroth, B. Andersson, 1992, Blood.

Expression of unusual immunophenotype combinations in acute myelogenous leukemia.

E. Estey, A. Deisseroth, L. Terstappen, 1993, Blood.

High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia.

S. Kornblau, T. Kobayashi, A. Deisseroth, 1995, Clinical Cancer Research.

Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.

N. Ueno, K. Cleary, B. Andersson, 1999, Blood.

High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.

B. Andersson, U. Popat, M. de Lima, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.

G. Hortobagyi, N. Ueno, B. Andersson, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma

J. Drabick, W. Rybka, D. Claxton, 2009, Bone Marrow Transplantation.

Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma

B. Andersson, R. Champlin, A. Shimoni, 2001, Bone Marrow Transplantation.

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma

J. Cox, F. Cabanillas, B. Andersson, 2004, Bone Marrow Transplantation.

Acanthamoeba meningoencephalitis after bone marrow transplantation.

M. Andreeff, A. Deisseroth, P. Anderlini, 1994, Bone marrow transplantation.

Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.

B. Andersson, K. van Besien, P. Miller, 1996, Bone marrow transplantation.

Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations.

J. Rowley, J. Ihle, G. Nucifora, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma.

N. Ueno, K. Cleary, B. Andersson, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.

P. Thall, G. Hortobagyi, R. Giles, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr–abl positive 32D myeloid leukemia cells

A. Deisseroth, J. Greenberger, Ilyas K. Colombowala, 1998, Oncogene.

Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation.

B. Andersson, K. van Besien, A. Deisseroth, 1995, Urology.